ONTOLOGY REPORT - ANNOTATIONS
| Term: | caffeine |
|
| Accession: | CHEBI:27732
|
browse the term
|
| Definition: | A trimethylxanthine in which the three methyl groups are located at positions 1, 3, and 7. |
| Synonyms: | exact_synonym: | 1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione |
| | related_synonym: | 1,3,7-trimethyl-2,6-dioxopurine; 1,3,7-trimethylpurine-2,6-dione; 1,3,7-trimethylxanthine; 1-methyltheobromine; 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion; 7-methyltheophylline; C8H10N4O2; Cn1cnc2n(C)c(=O)n(C)c(=O)c12; Coffein; InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3; InChIKey=RYYVLZVUVIJVGH-UHFFFAOYSA-N; Koffein; Thein; anhydrous caffeine; cafeina; cafeine; guaranine; mateina; methyltheobromine; teina; theine |
| | alt_id: | CHEBI:22982; CHEBI:3295; CHEBI:41472 |
| | xref_casrn: | 58-08-2 |
| | xref: | Beilstein:17705 "Beilstein Registry Number"; ChEMBL:116485 "ChEMBL COMPOUND"; ChemIDplus:58-08-2 "CAS Registry Number"; CiteXplore:10510174 "PubMed citation"; CiteXplore:10803761 "PubMed citation"; CiteXplore:10884512 "PubMed citation"; CiteXplore:10983026 "PubMed citation"; CiteXplore:11022879 "PubMed citation"; CiteXplore:11209966 "PubMed citation"; CiteXplore:11410911 "PubMed citation"; CiteXplore:11431501 "PubMed citation"; CiteXplore:11815511 "PubMed citation"; CiteXplore:11949272 "PubMed citation"; CiteXplore:12574990 "PubMed citation"; CiteXplore:12915014 "PubMed citation"; CiteXplore:12943586 "PubMed citation"; CiteXplore:14521986 "PubMed citation"; CiteXplore:14607010 "PubMed citation"; CiteXplore:15257305 "PubMed citation"; CiteXplore:15681408 "PubMed citation"; CiteXplore:15718055 "PubMed citation"; CiteXplore:16143823 "PubMed citation"; CiteXplore:16644114 "PubMed citation"; CiteXplore:16709440 "PubMed citation"; CiteXplore:16805851 "PubMed citation"; CiteXplore:16856769 "PubMed citation"; CiteXplore:17132260 "PubMed citation"; CiteXplore:17387608 "PubMed citation"; CiteXplore:17508167 "PubMed citation"; CiteXplore:17932622 "PubMed citation"; CiteXplore:18258404 "PubMed citation"; CiteXplore:18421070 "PubMed citation"; CiteXplore:18625110 "PubMed citation"; CiteXplore:18647558 "PubMed citation"; CiteXplore:19007524 "PubMed citation"; CiteXplore:19047957 "PubMed citation"; CiteXplore:19084078 "PubMed citation"; CiteXplore:19088793 "PubMed citation"; CiteXplore:19879252 "PubMed citation"; CiteXplore:20470411 "PubMed citation"; CiteXplore:22770225 "PubMed citation"; CiteXplore:7441110 "PubMed citation"; CiteXplore:7689104 "PubMed citation"; CiteXplore:8332255 "PubMed citation"; CiteXplore:8347173 "PubMed citation"; CiteXplore:8679661 "PubMed citation"; CiteXplore:9063686 "PubMed citation"; CiteXplore:9067318 "PubMed citation"; CiteXplore:9132918 "PubMed citation"; CiteXplore:9218278 "PubMed citation"; DrugBank:DB00201 "DrugBank"; Gmelin:103040 "Gmelin Registry Number"; HMDB:HMDB01847 "HMDB"; KEGG COMPOUND:58-08-2 "CAS Registry Number"; KEGG COMPOUND:C07481 "KEGG COMPOUND"; KEGG DRUG:D00528 "KEGG DRUG" |
| | xref_mesh: | MESH:D002110 |
| | xref: | MetaCyc:1-3-7-TRIMETHYLXANTHINE "MetaCyc"; NIST Chemistry WebBook:58-08-2 "CAS Registry Number"; PDBeChem:CFF "PDBeChem"; Reaxys:17705 "Reaxys Registry Number"; Wikipedia:Caffeine "Wikipedia" |
|
|
caffeine
|
| G |
ACAT2 |
acetyl-CoA acetyltransferase 2 |
|
decreases expression |
EXP |
6 |
160,182,989 |
160,200,087 |
RGD:6480464 |
CTD |
| G |
ACIN1 |
apoptotic chromatin condensation inducer 1 |
|
increases expression |
EXP |
14 |
23,527,773 |
23,564,823 |
RGD:6480464 |
CTD |
| G |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
|
increases expression |
EXP |
2 |
223,725,732 |
223,808,119 |
RGD:6480464 |
CTD |
| G |
ACTR1A |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
multiple interactions |
ISO |
10 |
104,238,986 |
104,262,512 |
RGD:6480464 |
CTD |
| G |
ADARB1 |
adenosine deaminase, RNA-specific, B1 |
|
decreases expression |
ISO |
21 |
46,494,493 |
46,646,478 |
RGD:6480464 |
CTD |
| G |
ADCK3 |
aarF domain containing kinase 3 |
|
multiple interactions |
ISO |
1 |
227,127,938 |
227,175,246 |
RGD:6480464 |
CTD |
| G |
ADCY7 |
adenylate cyclase 7 |
|
multiple interactions |
ISO |
16 |
50,321,823 |
50,352,043 |
RGD:6480464 |
CTD |
| G |
ADIPOR2 |
adiponectin receptor 2 |
|
increases expression |
ISO |
12 |
1,800,247 |
1,897,845 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
decreases activity |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
decreases expression |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
increases expression |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA1 |
adenosine A1 receptor |
|
decreases activity |
ISO |
1 |
203,096,836 |
203,136,533 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
increases response to substance |
EXP |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
affects response to substance |
EXP |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
increases response to substance |
EXP |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
increases response to substance |
EXP |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
affects response to substance |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
increases response to substance |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
affects binding |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
multiple interactions |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
multiple interactions |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
multiple interactions |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2A |
adenosine A2a receptor |
|
decreases expression |
ISO |
22 |
24,823,530 |
24,838,325 |
RGD:6480464 |
CTD |
| G |
ADORA2B |
adenosine A2b receptor |
|
multiple interactions |
EXP |
17 |
15,848,231 |
15,879,210 |
RGD:6480464 |
CTD |
| G |
AKR1A1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
multiple interactions |
ISO |
1 |
46,016,455 |
46,035,723 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases response to substance |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
ALDH18A1 |
aldehyde dehydrogenase 18 family, member A1 |
|
decreases expression |
EXP |
10 |
97,365,686 |
97,416,567 |
RGD:6480464 |
CTD |
| G |
ALDH1A1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
9 |
75,515,578 |
75,568,233 |
RGD:6480464 |
CTD |
| G |
ALDH9A1 |
aldehyde dehydrogenase 9 family, member A1 |
|
increases expression |
ISO |
1 |
165,631,449 |
165,667,900 |
RGD:6480464 |
CTD |
| G |
ANG |
angiogenin, ribonuclease, RNase A family, 5 |
|
decreases expression |
EXP |
14 |
21,152,336 |
21,162,345 |
RGD:6480464 |
CTD |
| G |
ANKRD37 |
ankyrin repeat domain 37 |
|
decreases expression |
ISO |
4 |
186,317,840 |
186,321,390 |
RGD:6480464 |
CTD |
| G |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions |
ISO |
14 |
20,923,290 |
20,925,931 |
RGD:6480464 |
CTD |
| G |
APOA1 |
apolipoprotein A-I |
|
multiple interactions |
EXP |
11 |
116,706,469 |
116,708,338 |
RGD:6480464 |
CTD |
| G |
APOA2 |
apolipoprotein A-II |
|
multiple interactions |
EXP |
1 |
161,192,083 |
161,193,418 |
RGD:6480464 |
CTD |
| G |
APOB |
apolipoprotein B (including Ag(x) antigen) |
|
multiple interactions |
EXP |
2 |
21,224,301 |
21,266,945 |
RGD:6480464 |
CTD |
| G |
APOC1 |
apolipoprotein C-I |
|
multiple interactions |
EXP |
19 |
45,417,921 |
45,422,606 |
RGD:6480464 |
CTD |
| G |
APOC2 |
apolipoprotein C-II |
|
multiple interactions |
EXP |
19 |
45,449,239 |
45,452,822 |
RGD:6480464 |
CTD |
| G |
APOC3 |
apolipoprotein C-III |
|
multiple interactions |
EXP |
11 |
116,700,624 |
116,703,787 |
RGD:6480464 |
CTD |
| G |
ARF1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
1 |
228,270,361 |
228,286,913 |
RGD:6480464 |
CTD |
| G |
ARL6IP1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
increases expression |
EXP |
16 |
18,802,991 |
18,812,857 |
RGD:6480464 |
CTD |
| G |
ARRB2 |
arrestin, beta 2 |
|
increases expression |
ISO |
17 |
4,613,789 |
4,624,795 |
RGD:6480464 |
CTD |
| G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression |
EXP |
7 |
97,481,429 |
97,501,854 |
RGD:6480464 |
CTD |
| G |
ATG7 |
autophagy related 7 |
|
increases response to substance |
ISO |
3 |
11,314,010 |
11,599,139 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
decreases activity |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
decreases activity |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects response to substance |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP5J2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 |
|
decreases expression |
EXP |
7 |
99,055,784 |
99,063,824 |
RGD:6480464 |
CTD |
| G |
ATP6V0C |
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
|
multiple interactions |
ISO |
16 |
2,563,727 |
2,570,224 |
RGD:6480464 |
CTD |
| G |
ATP6V1B2 |
ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 |
|
multiple interactions |
ISO |
8 |
20,054,704 |
20,079,207 |
RGD:6480464 |
CTD |
| G |
ATPAF1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
decreases expression |
ISO |
1 |
47,100,711 |
47,134,099 |
RGD:6480464 |
CTD |
| G |
ATR |
ataxia telangiectasia and Rad3 related |
|
affects activity |
EXP |
3 |
142,168,077 |
142,297,668 |
RGD:6480464 |
CTD |
| G |
ATR |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
EXP |
3 |
142,168,077 |
142,297,668 |
RGD:6480464 |
CTD |
| G |
ATR |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
EXP |
3 |
142,168,077 |
142,297,668 |
RGD:6480464 |
CTD |
| G |
ATR |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
EXP |
3 |
142,168,077 |
142,297,668 |
RGD:6480464 |
CTD |
| G |
ATRN |
attractin |
|
multiple interactions |
ISO |
20 |
3,451,665 |
3,631,769 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BBC3 |
BCL2 binding component 3 |
|
multiple interactions |
EXP |
19 |
47,724,079 |
47,736,023 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
multiple interactions |
ISO |
10 |
133,781,204 |
133,795,435 |
RGD:6480464 |
CTD |
| G |
C1R |
complement component 1, r subcomponent |
|
multiple interactions |
ISO |
12 12 |
7,241,205 7,187,513 |
7,245,043 7,189,412 |
RGD:6480464 |
CTD |
| G |
C1S |
complement component 1, s subcomponent |
|
multiple interactions |
ISO |
12 |
7,167,980 |
7,178,336 |
RGD:6480464 |
CTD |
| G |
C2CD5 |
C2 calcium-dependent domain containing 5 |
|
increases expression |
ISO |
12 |
22,601,517 |
22,697,452 |
RGD:6480464 |
CTD |
| G |
CALM1 |
calmodulin 1 (phosphorylase kinase, delta) |
|
multiple interactions |
ISO |
14 |
90,863,327 |
90,874,619 |
RGD:6480464 |
CTD |
| G |
CALU |
calumenin |
|
decreases expression |
EXP |
7 |
128,379,346 |
128,413,477 |
RGD:6480464 |
CTD |
| G |
CAPN1 |
calpain 1, (mu/I) large subunit |
|
multiple interactions |
EXP |
11 |
64,948,686 |
64,979,477 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
affects cleavage |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CBX5 |
chromobox homolog 5 |
|
multiple interactions |
ISO |
12 |
54,624,730 |
54,673,915 |
RGD:6480464 |
CTD |
| G |
CCDC174 |
coiled-coil domain containing 174 |
|
decreases expression |
ISO |
3 |
14,693,253 |
14,714,166 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
multiple interactions |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
increases expression |
ISO |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCNB1 |
cyclin B1 |
|
multiple interactions |
EXP |
5 |
68,462,837 |
68,474,072 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCNF |
cyclin F |
|
multiple interactions |
ISO |
16 |
2,479,395 |
2,508,859 |
RGD:6480464 |
CTD |
| G |
CCNL2 |
cyclin L2 |
|
multiple interactions |
ISO |
1 |
1,321,091 |
1,334,718 |
RGD:6480464 |
CTD |
| G |
CCZ1 |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
5,938,341 |
5,965,605 |
RGD:6480464 |
CTD |
| G |
CCZ1 |
CCZ1 vacuolar protein trafficking and biogenesis associated homolog (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
5,938,341 |
5,965,605 |
RGD:6480464 |
CTD |
| G |
CDC25B |
cell division cycle 25B |
|
increases expression |
ISO |
20 |
3,776,401 |
3,786,762 |
RGD:6480464 |
CTD |
| G |
CDC25C |
cell division cycle 25C |
|
decreases expression |
EXP |
5 |
137,620,959 |
137,667,516 |
RGD:6480464 |
CTD |
| G |
CDC25C |
cell division cycle 25C |
|
multiple interactions |
EXP |
5 |
137,620,959 |
137,667,516 |
RGD:6480464 |
CTD |
| G |
CDC25C |
cell division cycle 25C |
|
multiple interactions |
EXP |
5 |
137,620,959 |
137,667,516 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
increases expression |
ISO |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
|
multiple interactions |
ISO |
16 |
64,980,683 |
65,155,919 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
EXP |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
EXP |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
EXP |
10 |
62,538,089 |
62,554,610 |
RGD:6480464 |
CTD |
| G |
CDK2 |
cyclin-dependent kinase 2 |
|
decreases activity |
EXP |
12 |
56,360,556 |
56,366,568 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
decreases expression |
EXP |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CETN3 |
centrin, EF-hand protein, 3 |
|
multiple interactions |
ISO |
5 |
89,689,528 |
89,705,603 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
multiple interactions |
EXP |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
multiple interactions |
EXP |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
decreases phosphorylation |
EXP |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
multiple interactions |
EXP |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
decreases activity |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CKMT1B |
creatine kinase, mitochondrial 1B |
|
multiple interactions |
ISO |
15 |
43,885,252 |
43,891,604 |
RGD:6480464 |
CTD |
| G |
CLSTN1 |
calsyntenin 1 |
|
multiple interactions |
ISO |
1 |
9,789,079 |
9,884,550 |
RGD:6480464 |
CTD |
| G |
CNN2 |
calponin 2 |
|
multiple interactions |
ISO |
19 |
1,026,298 |
1,039,064 |
RGD:6480464 |
CTD |
| G |
COBL |
cordon-bleu WH2 repeat protein |
|
affects expression |
ISO |
7 |
51,083,909 |
51,384,515 |
RGD:6480464 |
CTD |
| G |
COCH |
coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression |
ISO |
14 |
31,343,741 |
31,359,822 |
RGD:6480464 |
CTD |
| G |
COCH |
coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression |
ISO |
14 |
31,343,741 |
31,359,822 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
multiple interactions |
ISO |
2 |
42,577,642 |
42,588,356 |
RGD:6480464 |
CTD |
| G |
COX7C |
cytochrome c oxidase subunit VIIc |
|
multiple interactions |
ISO |
5 |
85,913,784 |
85,916,583 |
RGD:6480464 |
CTD |
| G |
CSNK2A2 |
casein kinase 2, alpha prime polypeptide |
|
decreases expression |
ISO |
16 |
58,191,811 |
58,231,782 |
RGD:6480464 |
CTD |
| G |
CST3 |
cystatin C |
|
multiple interactions |
ISO |
20 |
23,614,294 |
23,618,574 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
increases mutagenesis |
ISO |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CTSB |
cathepsin B |
|
multiple interactions |
EXP |
8 |
11,700,033 |
11,725,646 |
RGD:6480464 |
CTD |
| G |
CTSB |
cathepsin B |
|
multiple interactions |
ISO |
8 |
11,700,033 |
11,725,646 |
RGD:6480464 |
CTD |
| G |
CTSL1 |
cathepsin L1 |
|
multiple interactions |
ISO |
9 |
90,340,974 |
90,346,384 |
RGD:6480464 |
CTD |
| G |
CYC1 |
cytochrome c-1 |
|
decreases expression |
EXP |
8 |
145,149,960 |
145,152,428 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
EXP |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases activity |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects binding |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases methylation |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases methylation |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases activity |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases methylation |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
affects metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
increases metabolic processing |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
multiple interactions |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2A6 |
cytochrome P450, family 2, subfamily A, polypeptide 6 |
|
increases metabolic processing |
EXP |
19 |
41,349,443 |
41,356,352 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
affects metabolic processing |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
affects metabolic processing |
EXP |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP4B1 |
cytochrome P450, family 4, subfamily B, polypeptide 1 |
|
increases expression |
EXP |
1 |
47,264,670 |
47,285,021 |
RGD:6480464 |
CTD |
| G |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
decreases expression |
ISO |
8 |
65,508,529 |
65,711,348 |
RGD:6480464 |
CTD |
| G |
DAD1 |
defender against cell death 1 |
|
decreases expression |
EXP |
14 |
23,033,807 |
23,058,143 |
RGD:6480464 |
CTD |
| G |
DCAF11 |
DDB1 and CUL4 associated factor 11 |
|
decreases expression |
ISO |
14 |
24,583,906 |
24,594,451 |
RGD:6480464 |
CTD |
| G |
DCT |
dopachrome tautomerase |
|
increases expression |
EXP |
13 |
95,091,835 |
95,131,936 |
RGD:6480464 |
CTD |
| G |
DCXR |
dicarbonyl/L-xylulose reductase |
|
multiple interactions |
ISO |
17 |
79,993,757 |
79,995,573 |
RGD:6480464 |
CTD |
| G |
DDHD1 |
DDHD domain containing 1 |
|
increases expression |
ISO |
14 |
53,503,458 |
53,620,046 |
RGD:6480464 |
CTD |
| G |
DDX31 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
decreases expression |
ISO |
9 |
135,469,676 |
135,545,788 |
RGD:6480464 |
CTD |
| G |
DHCR24 |
24-dehydrocholesterol reductase |
|
decreases expression |
ISO |
1 |
55,315,300 |
55,352,921 |
RGD:6480464 |
CTD |
| G |
DNAJA1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
ISO |
9 |
33,025,209 |
33,039,062 |
RGD:6480464 |
CTD |
| G |
DNAJB9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
ISO |
7 |
108,210,189 |
108,215,294 |
RGD:6480464 |
CTD |
| G |
DPP4 |
dipeptidyl-peptidase 4 |
|
multiple interactions |
ISO |
2 |
162,848,755 |
162,931,052 |
RGD:6480464 |
CTD |
| G |
DRD2 |
dopamine receptor D2 |
|
affects response to substance |
EXP |
11 |
113,280,317 |
113,346,001 |
RGD:6480464 |
CTD |
| G |
DRD2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
11 |
113,280,317 |
113,346,001 |
RGD:6480464 |
CTD |
| G |
DRD2 |
dopamine receptor D2 |
|
increases response to substance |
ISO |
11 |
113,280,317 |
113,346,001 |
RGD:6480464 |
CTD |
| G |
DTX4 |
deltex homolog 4 (Drosophila) |
|
decreases expression |
ISO |
11 |
58,939,812 |
58,976,060 |
RGD:6480464 |
CTD |
| G |
DUSP8 |
dual specificity phosphatase 8 |
|
increases expression |
ISO |
11 |
1,575,281 |
1,593,150 |
RGD:6480464 |
CTD |
| G |
EBPL |
emopamil binding protein-like |
|
decreases expression |
ISO |
13 |
50,234,810 |
50,265,623 |
RGD:6480464 |
CTD |
| G |
ECI1 |
enoyl-CoA delta isomerase 1 |
|
decreases expression |
ISO |
16 |
2,289,873 |
2,301,602 |
RGD:6480464 |
CTD |
| G |
ECM1 |
extracellular matrix protein 1 |
|
multiple interactions |
ISO |
1 |
150,480,487 |
150,486,265 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
increases activity |
ISO |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EEF1A1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions |
ISO |
6 |
74,225,473 |
74,230,755 |
RGD:6480464 |
CTD |
| G |
EEF2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
ISO |
19 |
3,976,054 |
3,985,461 |
RGD:6480464 |
CTD |
| G |
EFNA1 |
ephrin-A1 |
|
multiple interactions |
ISO |
1 |
155,100,349 |
155,107,386 |
RGD:6480464 |
CTD |
| G |
EFNB3 |
ephrin-B3 |
|
multiple interactions |
ISO |
17 |
7,608,520 |
7,614,693 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
increases expression |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
decreases expression |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EIF1 |
eukaryotic translation initiation factor 1 |
|
increases expression |
EXP |
17 |
39,845,127 |
39,847,898 |
RGD:6480464 |
CTD |
| G |
EIF4E |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
4 |
99,799,607 |
99,851,786 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
EXP |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
ISO |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
decreases expression |
ISO |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
EIF5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
ISO |
14 |
103,800,339 |
103,811,362 |
RGD:6480464 |
CTD |
| G |
ELL |
elongation factor RNA polymerase II |
|
decreases expression |
ISO |
19 |
18,553,473 |
18,632,937 |
RGD:6480464 |
CTD |
| G |
EMC6 |
ER membrane protein complex subunit 6 |
|
decreases expression |
ISO |
17 |
3,572,090 |
3,572,962 |
RGD:6480464 |
CTD |
| G |
ENDOD1 |
endonuclease domain containing 1 |
|
decreases expression |
ISO |
11 |
94,822,974 |
94,865,815 |
RGD:6480464 |
CTD |
| G |
ENO1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
1 |
8,921,059 |
8,939,151 |
RGD:6480464 |
CTD |
| G |
ENO1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
1 |
8,921,059 |
8,939,151 |
RGD:6480464 |
CTD |
| G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions |
ISO |
17 |
62,120,390 |
62,207,502 |
RGD:6480464 |
CTD |
| G |
ERP44 |
endoplasmic reticulum protein 44 |
|
multiple interactions |
ISO |
9 |
102,741,461 |
102,861,330 |
RGD:6480464 |
CTD |
| G |
ESYT2 |
extended synaptotagmin-like protein 2 |
|
decreases expression |
ISO |
7 |
158,523,689 |
158,622,319 |
RGD:6480464 |
CTD |
| G |
EZR |
ezrin |
|
multiple interactions |
ISO |
6 |
159,186,773 |
159,240,456 |
RGD:6480464 |
CTD |
| G |
FASTKD3 |
FAST kinase domains 3 |
|
decreases expression |
ISO |
5 |
7,859,272 |
7,869,150 |
RGD:6480464 |
CTD |
| G |
FBLN2 |
fibulin 2 |
|
increases expression |
ISO |
3 |
13,590,625 |
13,679,922 |
RGD:6480464 |
CTD |
| G |
FBRS |
fibrosin |
|
increases expression |
ISO |
16 |
30,675,778 |
30,682,131 |
RGD:6480464 |
CTD |
| G |
FBXL12 |
F-box and leucine-rich repeat protein 12 |
|
multiple interactions |
ISO |
19 |
9,920,943 |
9,929,731 |
RGD:6480464 |
CTD |
| G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
|
decreases expression |
ISO |
8 |
11,660,190 |
11,696,818 |
RGD:6480464 |
CTD |
| G |
FDX1 |
ferredoxin 1 |
|
decreases expression |
ISO |
11 |
110,300,661 |
110,335,608 |
RGD:6480464 |
CTD |
| G |
FHL1 |
four and a half LIM domains 1 |
|
increases expression |
ISO |
X |
135,228,861 |
135,293,518 |
RGD:6480464 |
CTD |
| G |
FILIP1L |
filamin A interacting protein 1-like |
|
increases expression |
ISO |
3 |
99,551,988 |
99,833,349 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FUK |
fucokinase |
|
increases expression |
ISO |
16 |
70,488,498 |
70,514,177 |
RGD:6480464 |
CTD |
| G |
FYN |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
ISO |
6 |
111,981,535 |
112,194,655 |
RGD:6480464 |
CTD |
| G |
GALE |
UDP-galactose-4-epimerase |
|
multiple interactions |
ISO |
1 |
24,122,089 |
24,127,294 |
RGD:6480464 |
CTD |
| G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
12 |
6,643,585 |
6,647,537 |
RGD:6480464 |
CTD |
| G |
GAST |
gastrin |
|
increases secretion |
ISO |
17 |
39,868,578 |
39,872,221 |
RGD:6480464 |
CTD |
| G |
GDF10 |
growth differentiation factor 10 |
|
decreases expression |
ISO |
10 |
48,425,785 |
48,439,138 |
RGD:6480464 |
CTD |
| G |
GFAP |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
17 |
42,982,994 |
42,992,920 |
RGD:6480464 |
CTD |
| G |
GH1 |
growth hormone 1 |
|
multiple interactions |
EXP |
17 |
61,994,563 |
61,996,198 |
RGD:6480464 |
CTD |
| G |
GHITM |
growth hormone inducible transmembrane protein |
|
multiple interactions |
ISO |
10 |
85,899,185 |
85,913,311 |
RGD:6480464 |
CTD |
| G |
GLRX |
glutaredoxin (thioltransferase) |
|
decreases expression |
EXP |
5 |
95,149,553 |
95,158,577 |
RGD:6480464 |
CTD |
| G |
GLT8D1 |
glycosyltransferase 8 domain containing 1 |
|
decreases expression |
EXP |
3 |
52,728,504 |
52,740,048 |
RGD:6480464 |
CTD |
| G |
GLUD1 |
glutamate dehydrogenase 1 |
|
decreases expression |
EXP |
10 |
88,809,959 |
88,854,776 |
RGD:6480464 |
CTD |
| G |
GMFB |
glia maturation factor, beta |
|
multiple interactions |
ISO |
14 |
54,941,209 |
54,955,744 |
RGD:6480464 |
CTD |
| G |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
decreases expression |
ISO |
7 |
79,764,140 |
79,848,725 |
RGD:6480464 |
CTD |
| G |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
increases expression |
ISO |
7 |
79,764,140 |
79,848,725 |
RGD:6480464 |
CTD |
| G |
GNAI2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
decreases expression |
ISO |
3 |
50,273,647 |
50,296,786 |
RGD:6480464 |
CTD |
| G |
GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
|
increases response to substance |
ISO |
18 |
11,689,014 |
11,885,684 |
RGD:6480464 |
CTD |
| G |
GNAQ |
guanine nucleotide binding protein (G protein), q polypeptide |
|
decreases expression |
ISO |
9 |
80,335,189 |
80,646,219 |
RGD:6480464 |
CTD |
| G |
GNAS |
GNAS complex locus |
|
decreases expression |
ISO |
20 |
57,414,795 |
57,486,250 |
RGD:6480464 |
CTD |
| G |
GOLT1B |
golgi transport 1B |
|
multiple interactions |
ISO |
12 |
21,654,699 |
21,671,337 |
RGD:6480464 |
CTD |
| G |
GOSR1 |
golgi SNAP receptor complex member 1 |
|
decreases expression |
ISO |
17 |
28,804,426 |
28,853,832 |
RGD:6480464 |
CTD |
| G |
GPC3 |
glypican 3 |
|
affects expression |
ISO |
X |
132,669,773 |
133,119,673 |
RGD:6480464 |
CTD |
| G |
GPT |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
ISO |
8 |
145,729,465 |
145,732,555 |
RGD:6480464 |
CTD |
| G |
GPX3 |
glutathione peroxidase 3 (plasma) |
|
multiple interactions |
ISO |
5 |
150,399,999 |
150,408,554 |
RGD:6480464 |
CTD |
| G |
GRID2 |
glutamate receptor, ionotropic, delta 2 |
|
multiple interactions |
ISO |
4 |
93,225,550 |
94,693,649 |
RGD:6480464 |
CTD |
| G |
GRM1 |
glutamate receptor, metabotropic 1 |
|
decreases expression |
ISO |
6 |
146,348,782 |
146,758,731 |
RGD:6480464 |
CTD |
| G |
GRPR |
gastrin-releasing peptide receptor |
|
decreases expression |
ISO |
X |
16,141,424 |
16,171,641 |
RGD:6480464 |
CTD |
| G |
GRWD1 |
glutamate-rich WD repeat containing 1 |
|
decreases expression |
ISO |
19 |
48,949,030 |
48,957,164 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
increases phosphorylation |
EXP |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
multiple interactions |
EXP |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
decreases phosphorylation |
ISO |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSTO1 |
glutathione S-transferase omega 1 |
|
decreases expression |
EXP |
10 |
106,013,952 |
106,027,222 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
ISO |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
HBA2 |
hemoglobin, alpha 2 |
|
multiple interactions |
ISO |
16 |
222,846 |
223,709 |
RGD:6480464 |
CTD |
| G |
HECA |
headcase homolog (Drosophila) |
|
increases expression |
ISO |
6 |
139,456,249 |
139,501,946 |
RGD:6480464 |
CTD |
| G |
HELLS |
helicase, lymphoid-specific |
|
multiple interactions |
ISO |
10 |
96,305,574 |
96,361,856 |
RGD:6480464 |
CTD |
| G |
HELLS |
helicase, lymphoid-specific |
|
increases expression |
ISO |
10 |
96,305,574 |
96,361,856 |
RGD:6480464 |
CTD |
| G |
HINT1 |
histidine triad nucleotide binding protein 1 |
|
multiple interactions |
ISO |
5 |
130,494,875 |
130,501,034 |
RGD:6480464 |
CTD |
| G |
HMGCS1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
decreases expression |
ISO |
5 |
43,287,572 |
43,313,614 |
RGD:6480464 |
CTD |
| G |
HOMER1 |
homer homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
5 |
78,669,786 |
78,809,700 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HSD11B1 |
hydroxysteroid (11-beta) dehydrogenase 1 |
|
increases expression |
ISO |
1 |
209,859,525 |
209,908,295 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
decreases expression |
ISO |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
decreases expression |
EXP |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
multiple interactions |
EXP |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD17B7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
decreases expression |
ISO |
1 |
162,760,496 |
162,782,608 |
RGD:6480464 |
CTD |
| G |
HSP90AA1 |
heat shock protein 90kDa alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
14 |
102,547,075 |
102,606,086 |
RGD:6480464 |
CTD |
| G |
HSPB1 |
heat shock 27kDa protein 1 |
|
increases expression |
ISO |
7 |
75,931,875 |
75,933,614 |
RGD:6480464 |
CTD |
| G |
HSPB6 |
heat shock protein, alpha-crystallin-related, B6 |
|
increases expression |
ISO |
19 |
36,245,467 |
36,247,930 |
RGD:6480464 |
CTD |
| G |
HSPE1 |
heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
2 |
198,364,721 |
198,368,187 |
RGD:6480464 |
CTD |
| G |
HSPE1 |
heat shock 10kDa protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
2 |
198,364,721 |
198,368,187 |
RGD:6480464 |
CTD |
| G |
ID3 |
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein |
|
increases expression |
ISO |
1 |
23,884,421 |
23,886,285 |
RGD:6480464 |
CTD |
| G |
IDI1 |
isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression |
ISO |
10 |
1,085,963 |
1,095,061 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
decreases secretion |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
decreases expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGF1R |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
15 |
99,192,761 |
99,507,759 |
RGD:6480464 |
CTD |
| G |
IGFBP1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
7 |
45,927,959 |
45,933,267 |
RGD:6480464 |
CTD |
| G |
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
increases expression |
ISO |
8 |
42,128,820 |
42,190,171 |
RGD:6480464 |
CTD |
| G |
IL10RB |
interleukin 10 receptor, beta |
|
increases expression |
ISO |
21 |
34,638,665 |
34,669,539 |
RGD:6480464 |
CTD |
| G |
IL1RL1 |
interleukin 1 receptor-like 1 |
|
increases expression |
ISO |
2 |
102,927,962 |
102,968,497 |
RGD:6480464 |
CTD |
| G |
IL4R |
interleukin 4 receptor |
|
increases expression |
ISO |
16 |
27,325,230 |
27,376,099 |
RGD:6480464 |
CTD |
| G |
IL4R |
interleukin 4 receptor |
|
multiple interactions |
ISO |
16 |
27,325,230 |
27,376,099 |
RGD:6480464 |
CTD |
| G |
INO80C |
INO80 complex subunit C |
|
decreases expression |
ISO |
18 |
33,048,291 |
33,077,955 |
RGD:6480464 |
CTD |
| G |
INS |
insulin |
|
multiple interactions |
EXP |
11 |
2,181,009 |
2,182,439 |
RGD:6480464 |
CTD |
| G |
INSIG1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
7 |
155,089,486 |
155,101,945 |
RGD:6480464 |
CTD |
| G |
INSR |
insulin receptor |
|
decreases expression |
ISO |
19 |
7,112,266 |
7,294,011 |
RGD:6480464 |
CTD |
| G |
IRAK1 |
interleukin-1 receptor-associated kinase 1 |
|
multiple interactions |
ISO |
X |
153,275,957 |
153,285,342 |
RGD:6480464 |
CTD |
| G |
IRX3 |
iroquois homeobox 3 |
|
multiple interactions |
ISO |
16 |
54,317,212 |
54,320,378 |
RGD:6480464 |
CTD |
| G |
ITGAM |
integrin, alpha M (complement component 3 receptor 3 subunit) |
|
multiple interactions |
ISO |
16 |
31,271,288 |
31,344,213 |
RGD:6480464 |
CTD |
| G |
ITM2B |
integral membrane protein 2B |
|
multiple interactions |
ISO |
13 |
48,807,274 |
48,836,232 |
RGD:6480464 |
CTD |
| G |
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
|
decreases expression |
EXP |
3 |
4,535,032 |
4,889,524 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
decreases phosphorylation |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
KCTD14 |
potassium channel tetramerisation domain containing 14 |
|
decreases expression |
ISO |
11 |
77,726,761 |
77,734,320 |
RGD:6480464 |
CTD |
| G |
KIDINS220 |
kinase D-interacting substrate, 220kDa |
|
increases expression |
ISO |
2 |
8,868,987 |
8,977,755 |
RGD:6480464 |
CTD |
| G |
KIF3B |
kinesin family member 3B |
|
multiple interactions |
ISO |
20 |
30,865,454 |
30,922,814 |
RGD:6480464 |
CTD |
| G |
KLF4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
9 |
110,247,133 |
110,252,047 |
RGD:6480464 |
CTD |
| G |
LDHA |
lactate dehydrogenase A |
|
decreases expression |
EXP |
11 |
18,415,936 |
18,429,765 |
RGD:6480464 |
CTD |
| G |
LEPR |
leptin receptor |
|
increases expression |
ISO |
1 |
65,886,335 |
66,103,176 |
RGD:6480464 |
CTD |
| G |
LEPREL2 |
leprecan-like 2 |
|
multiple interactions |
ISO |
12 |
6,937,572 |
6,949,018 |
RGD:6480464 |
CTD |
| G |
LPAR4 |
lysophosphatidic acid receptor 4 |
|
multiple interactions |
ISO |
X |
78,003,206 |
78,012,588 |
RGD:6480464 |
CTD |
| G |
LPHN1 |
latrophilin 1 |
|
multiple interactions |
ISO |
19 |
14,258,549 |
14,316,997 |
RGD:6480464 |
CTD |
| G |
LYSMD2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression |
ISO |
15 |
52,015,261 |
52,043,650 |
RGD:6480464 |
CTD |
| G |
MAOA |
monoamine oxidase A |
|
multiple interactions |
ISO |
X |
43,514,155 |
43,606,071 |
RGD:6480464 |
CTD |
| G |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
|
multiple interactions |
ISO |
19 |
7,968,765 |
7,979,363 |
RGD:6480464 |
CTD |
| G |
MAP3K12 |
mitogen-activated protein kinase kinase kinase 12 |
|
multiple interactions |
ISO |
12 |
53,874,276 |
53,893,444 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases expression |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK15 |
mitogen-activated protein kinase 15 |
|
increases expression |
ISO |
8 |
144,798,507 |
144,804,633 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases expression |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MARCH11 |
membrane-associated ring finger (C3HC4) 11 |
|
decreases expression |
ISO |
5 |
16,067,474 |
16,179,897 |
RGD:6480464 |
CTD |
| G |
MARCH11 |
membrane-associated ring finger (C3HC4) 11 |
|
decreases expression |
ISO |
5 |
16,067,474 |
16,179,897 |
RGD:6480464 |
CTD |
| G |
MC2R |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
multiple interactions |
ISO |
18 |
13,882,043 |
13,915,535 |
RGD:6480464 |
CTD |
| G |
MCM3 |
minichromosome maintenance complex component 3 |
|
increases expression |
ISO |
6 |
52,128,812 |
52,149,679 |
RGD:6480464 |
CTD |
| G |
MGST1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
EXP |
12 |
16,500,076 |
16,530,123 |
RGD:6480464 |
CTD |
| G |
MICB |
MHC class I polypeptide-related sequence B |
|
multiple interactions |
EXP |
6 |
31,465,855 |
31,478,901 |
RGD:6480464 |
CTD |
| G |
MICB |
MHC class I polypeptide-related sequence B |
|
multiple interactions |
EXP |
6 |
31,465,855 |
31,478,901 |
RGD:6480464 |
CTD |
| G |
MMP7 |
matrix metallopeptidase 7 (matrilysin, uterine) |
|
multiple interactions |
ISO |
11 |
102,391,239 |
102,401,478 |
RGD:6480464 |
CTD |
| G |
MOGAT1 |
monoacylglycerol O-acyltransferase 1 |
|
decreases expression |
ISO |
2 |
223,536,457 |
223,574,649 |
RGD:6480464 |
CTD |
| G |
MOGAT1 |
monoacylglycerol O-acyltransferase 1 |
|
decreases expression |
ISO |
2 |
223,536,457 |
223,574,649 |
RGD:6480464 |
CTD |
| G |
MRPL19 |
mitochondrial ribosomal protein L19 |
|
decreases expression |
ISO |
2 |
75,873,909 |
75,889,334 |
RGD:6480464 |
CTD |
| G |
MRPL20 |
mitochondrial ribosomal protein L20 |
|
multiple interactions |
ISO |
1 |
1,337,276 |
1,342,693 |
RGD:6480464 |
CTD |
| G |
MRPL9 |
mitochondrial ribosomal protein L9 |
|
multiple interactions |
ISO |
1 |
151,732,123 |
151,736,040 |
RGD:6480464 |
CTD |
| G |
MSH2 |
mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) |
|
decreases expression |
ISO |
2 |
47,630,206 |
47,710,367 |
RGD:6480464 |
CTD |
| G |
MSMO1 |
methylsterol monooxygenase 1 |
|
decreases expression |
ISO |
4 |
166,248,818 |
166,264,316 |
RGD:6480464 |
CTD |
| G |
MT1G |
metallothionein 1G |
|
increases expression |
EXP |
16 |
56,700,653 |
56,701,977 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
multiple interactions |
ISO |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MTCH1 |
mitochondrial carrier 1 |
|
multiple interactions |
ISO |
6 |
36,935,917 |
36,953,949 |
RGD:6480464 |
CTD |
| G |
MTF2 |
metal response element binding transcription factor 2 |
|
multiple interactions |
ISO |
1 |
93,544,792 |
93,604,638 |
RGD:6480464 |
CTD |
| G |
MTHFD2L |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like |
|
decreases expression |
ISO |
4 |
75,023,829 |
75,168,816 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases activity |
EXP |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MTRR |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
|
decreases expression |
ISO |
5 |
7,869,217 |
7,901,237 |
RGD:6480464 |
CTD |
| G |
MUTYH |
mutY homolog (E. coli) |
|
increases expression |
ISO |
1 |
45,794,914 |
45,806,142 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
increases acetylation |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
affects metabolic processing |
EXP |
8 |
18,248,755 |
18,258,723 |
RGD:6480464 |
CTD |
| G |
NDUFB5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa |
|
multiple interactions |
ISO |
3 |
179,322,575 |
179,342,288 |
RGD:6480464 |
CTD |
| G |
NDUFS4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
|
multiple interactions |
ISO |
5 |
52,856,465 |
52,979,171 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NISCH |
nischarin |
|
multiple interactions |
ISO |
3 |
52,489,524 |
52,527,088 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NPL |
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) |
|
multiple interactions |
ISO |
1 |
182,758,584 |
182,799,519 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
multiple interactions |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
|
increases expression |
ISO |
4 |
148,999,915 |
149,363,672 |
RGD:6480464 |
CTD |
| G |
NRF1 |
nuclear respiratory factor 1 |
|
decreases expression |
ISO |
7 |
129,251,555 |
129,396,922 |
RGD:6480464 |
CTD |
| G |
NSF |
N-ethylmaleimide-sensitive factor |
|
multiple interactions |
ISO |
17 |
44,668,035 |
44,834,830 |
RGD:6480464 |
CTD |
| G |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
|
multiple interactions |
ISO |
16 |
28,548,662 |
28,550,495 |
RGD:6480464 |
CTD |
| G |
OAT |
ornithine aminotransferase |
|
increases expression |
EXP |
10 |
126,085,872 |
126,107,545 |
RGD:6480464 |
CTD |
| G |
ORM1 |
orosomucoid 1 |
|
increases expression |
ISO |
9 |
117,085,303 |
117,088,759 |
RGD:6480464 |
CTD |
| G |
ORM2 |
orosomucoid 2 |
|
increases expression |
ISO |
9 |
117,092,069 |
117,095,536 |
RGD:6480464 |
CTD |
| G |
OXSR1 |
oxidative-stress responsive 1 |
|
increases expression |
ISO |
3 |
38,207,026 |
38,296,979 |
RGD:6480464 |
CTD |
| G |
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
increases activity |
EXP |
3 |
196,466,728 |
196,559,518 |
RGD:6480464 |
CTD |
| G |
PAK2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
multiple interactions |
ISO |
3 |
196,466,728 |
196,559,518 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
affects cleavage |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PDE11A |
phosphodiesterase 11A |
|
decreases expression |
ISO |
2 |
178,487,977 |
178,973,066 |
RGD:6480464 |
CTD |
| G |
PDE5A |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
ISO |
4 |
120,415,550 |
120,549,981 |
RGD:6480464 |
CTD |
| G |
PDHX |
pyruvate dehydrogenase complex, component X |
|
decreases expression |
ISO |
11 |
34,937,677 |
35,017,675 |
RGD:6480464 |
CTD |
| G |
PDHX |
pyruvate dehydrogenase complex, component X |
|
decreases expression |
ISO |
11 |
34,937,677 |
35,017,675 |
RGD:6480464 |
CTD |
| G |
PDIA6 |
protein disulfide isomerase family A, member 6 |
|
multiple interactions |
ISO |
2 |
10,923,517 |
10,952,960 |
RGD:6480464 |
CTD |
| G |
PFDN1 |
prefoldin subunit 1 |
|
multiple interactions |
ISO |
5 |
139,624,635 |
139,682,689 |
RGD:6480464 |
CTD |
| G |
PGR |
progesterone receptor |
|
increases expression |
ISO |
11 |
100,900,355 |
101,000,544 |
RGD:6480464 |
CTD |
| G |
PHB |
prohibitin |
|
multiple interactions |
ISO |
17 |
47,481,420 |
47,492,242 |
RGD:6480464 |
CTD |
| G |
PHEX |
phosphate regulating endopeptidase homolog, X-linked |
|
increases expression |
ISO |
X |
22,050,921 |
22,266,478 |
RGD:6480464 |
CTD |
| G |
PHTF1 |
putative homeodomain transcription factor 1 |
|
multiple interactions |
ISO |
1 |
114,239,824 |
114,301,777 |
RGD:6480464 |
CTD |
| G |
PIDD |
p53-induced death domain protein |
|
multiple interactions |
ISO |
11 |
799,179 |
805,250 |
RGD:6480464 |
CTD |
| G |
PIGC |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
multiple interactions |
ISO |
1 |
172,410,597 |
172,413,230 |
RGD:6480464 |
CTD |
| G |
PIP5K1C |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
|
multiple interactions |
ISO |
19 |
3,630,179 |
3,700,477 |
RGD:6480464 |
CTD |
| G |
PITX2 |
paired-like homeodomain 2 |
|
decreases expression |
ISO |
4 |
111,538,579 |
111,563,279 |
RGD:6480464 |
CTD |
| G |
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
|
multiple interactions |
ISO |
16 |
2,138,711 |
2,185,899 |
RGD:6480464 |
CTD |
| G |
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
|
affects response to substance |
ISO |
16 |
2,138,711 |
2,185,899 |
RGD:6480464 |
CTD |
| G |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
multiple interactions |
ISO |
20 |
8,113,296 |
8,865,547 |
RGD:6480464 |
CTD |
| G |
PLCB1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
decreases expression |
ISO |
20 |
8,113,296 |
8,865,547 |
RGD:6480464 |
CTD |
| G |
PLP1 |
proteolipid protein 1 |
|
increases expression |
EXP |
X |
103,031,439 |
103,047,548 |
RGD:6480464 |
CTD |
| G |
PNPLA8 |
patatin-like phospholipase domain containing 8 |
|
multiple interactions |
ISO |
7 |
108,110,866 |
108,168,605 |
RGD:6480464 |
CTD |
| G |
POMC |
proopiomelanocortin |
|
increases secretion |
ISO |
2 |
25,383,722 |
25,391,559 |
RGD:6480464 |
CTD |
| G |
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
multiple interactions |
ISO |
2 |
44,396,000 |
44,461,742 |
RGD:6480464 |
CTD |
| G |
PPP2R2B |
protein phosphatase 2, regulatory subunit B, beta |
|
decreases expression |
EXP |
5 |
145,969,067 |
146,461,033 |
RGD:6480464 |
CTD |
| G |
PPP2R3C |
protein phosphatase 2, regulatory subunit B'', gamma |
|
multiple interactions |
ISO |
14 |
35,554,678 |
35,591,519 |
RGD:6480464 |
CTD |
| G |
PRELID1 |
PRELI domain containing 1 |
|
decreases expression |
EXP |
5 |
176,730,835 |
176,733,950 |
RGD:6480464 |
CTD |
| G |
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
increases expression |
ISO |
1 |
57,110,990 |
57,181,008 |
RGD:6480464 |
CTD |
| G |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
|
multiple interactions |
EXP |
8 |
48,685,669 |
48,872,743 |
RGD:6480464 |
CTD |
| G |
PRKDC |
protein kinase, DNA-activated, catalytic polypeptide |
|
multiple interactions |
ISO |
8 |
48,685,669 |
48,872,743 |
RGD:6480464 |
CTD |
| G |
PRNP |
prion protein |
|
decreases expression |
EXP |
20 |
4,666,797 |
4,682,234 |
RGD:6480464 |
CTD |
| G |
PRORSD1P |
prolyl-tRNA synthetase associated domain containing 1, pseudogene |
|
decreases expression |
ISO |
2 |
55,509,455 |
55,511,608 |
RGD:6480464 |
CTD |
| G |
PSMC5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
multiple interactions |
ISO |
17 |
61,904,770 |
61,909,387 |
RGD:6480464 |
CTD |
| G |
PSME3 |
proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki) |
|
decreases expression |
EXP |
17 |
40,985,159 |
40,995,777 |
RGD:6480464 |
CTD |
| G |
PTGFRN |
prostaglandin F2 receptor inhibitor |
|
increases expression |
ISO |
1 |
117,452,689 |
117,532,972 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
|
decreases expression |
ISO |
10 |
17,631,958 |
17,659,373 |
RGD:6480464 |
CTD |
| G |
PWP2 |
PWP2 periodic tryptophan protein homolog (yeast) |
|
decreases expression |
ISO |
21 |
45,527,208 |
45,551,063 |
RGD:6480464 |
CTD |
| G |
QRSL1 |
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
|
decreases expression |
ISO |
6 |
107,077,441 |
107,116,292 |
RGD:6480464 |
CTD |
| G |
RAB3IP |
RAB3A interacting protein |
|
increases expression |
ISO |
12 |
70,132,631 |
70,216,984 |
RGD:6480464 |
CTD |
| G |
RAB7A |
RAB7A, member RAS oncogene family |
|
multiple interactions |
ISO |
3 |
128,444,979 |
128,533,641 |
RGD:6480464 |
CTD |
| G |
RABGEF1 |
RAB guanine nucleotide exchange factor (GEF) 1 |
|
decreases expression |
ISO |
7 |
66,205,643 |
66,276,451 |
RGD:6480464 |
CTD |
| G |
RABL3 |
RAB, member of RAS oncogene family-like 3 |
|
decreases expression |
ISO |
3 |
120,405,528 |
120,461,384 |
RGD:6480464 |
CTD |
| G |
RAD1 |
RAD1 homolog (S. pombe) |
|
multiple interactions |
ISO |
5 |
34,905,365 |
34,915,780 |
RGD:6480464 |
CTD |
| G |
RAD50 |
RAD50 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
5 |
131,892,616 |
131,980,313 |
RGD:6480464 |
CTD |
| G |
RAD51AP1 |
RAD51 associated protein 1 |
|
increases expression |
ISO |
12 |
4,647,950 |
4,669,213 |
RGD:6480464 |
CTD |
| G |
RASA3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
13 |
114,747,194 |
114,898,095 |
RGD:6480464 |
CTD |
| G |
RASA3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
13 |
114,747,194 |
114,898,095 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
decreases phosphorylation |
ISO |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
decreases phosphorylation |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RBBP4 |
retinoblastoma binding protein 4 |
|
multiple interactions |
ISO |
1 |
33,116,749 |
33,151,812 |
RGD:6480464 |
CTD |
| G |
RBBP5 |
retinoblastoma binding protein 5 |
|
multiple interactions |
ISO |
1 |
205,055,270 |
205,091,150 |
RGD:6480464 |
CTD |
| G |
RBM12 |
RNA binding motif protein 12 |
|
decreases expression |
ISO |
20 |
34,236,847 |
34,252,878 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
increases activity |
ISO |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
increases expression |
ISO |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
increases activity |
EXP |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
increases activity |
ISO |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
increases secretion |
ISO |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
RGS2 |
regulator of G-protein signaling 2, 24kDa |
|
multiple interactions |
ISO |
1 |
192,778,169 |
192,781,407 |
RGD:6480464 |
CTD |
| G |
RHEBL1 |
Ras homolog enriched in brain like 1 |
|
increases expression |
ISO |
12 |
49,458,468 |
49,463,775 |
RGD:6480464 |
CTD |
| G |
RIMS2 |
regulating synaptic membrane exocytosis 2 |
|
decreases expression |
ISO |
8 |
104,512,976 |
105,266,656 |
RGD:6480464 |
CTD |
| G |
RNF166 |
ring finger protein 166 |
|
increases expression |
ISO |
16 |
88,762,903 |
88,772,829 |
RGD:6480464 |
CTD |
| G |
RPIA |
ribose 5-phosphate isomerase A |
|
decreases expression |
ISO |
2 |
88,991,176 |
89,050,452 |
RGD:6480464 |
CTD |
| G |
RPL26 |
ribosomal protein L26 |
|
multiple interactions |
ISO |
17 |
8,280,834 |
8,286,565 |
RGD:6480464 |
CTD |
| G |
RPL5 |
ribosomal protein L5 |
|
multiple interactions |
ISO |
1 |
93,297,594 |
93,307,481 |
RGD:6480464 |
CTD |
| G |
RPS6 |
ribosomal protein S6 |
|
decreases expression |
ISO |
9 |
19,376,254 |
19,380,235 |
RGD:6480464 |
CTD |
| G |
RPS6 |
ribosomal protein S6 |
|
decreases expression |
EXP |
9 |
19,376,254 |
19,380,235 |
RGD:6480464 |
CTD |
| G |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
|
decreases expression |
EXP |
X |
20,168,029 |
20,284,750 |
RGD:6480464 |
CTD |
| G |
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
decreases expression |
EXP |
17 |
57,970,443 |
58,027,787 |
RGD:6480464 |
CTD |
| G |
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
decreases expression |
ISO |
17 |
57,970,443 |
58,027,787 |
RGD:6480464 |
CTD |
| G |
RRS1 |
RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) |
|
increases expression |
EXP |
8 |
67,341,263 |
67,342,968 |
RGD:6480464 |
CTD |
| G |
RSPO3 |
R-spondin 3 |
|
multiple interactions |
ISO |
6 |
127,440,048 |
127,518,184 |
RGD:6480464 |
CTD |
| G |
RWDD2B |
RWD domain containing 2B |
|
decreases expression |
ISO |
21 |
30,378,080 |
30,391,685 |
RGD:6480464 |
CTD |
| G |
RYR1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
ISO |
19 |
38,924,340 |
39,078,204 |
RGD:6480464 |
CTD |
| G |
RYR1 |
ryanodine receptor 1 (skeletal) |
|
increases activity |
ISO |
19 |
38,924,340 |
39,078,204 |
RGD:6480464 |
CTD |
| G |
RYR1 |
ryanodine receptor 1 (skeletal) |
|
multiple interactions |
EXP |
19 |
38,924,340 |
39,078,204 |
RGD:6480464 |
CTD |
| G |
RYR1 |
ryanodine receptor 1 (skeletal) |
|
increases activity |
EXP |
19 |
38,924,340 |
39,078,204 |
RGD:6480464 |
CTD |
| G |
RYR2 |
ryanodine receptor 2 (cardiac) |
|
multiple interactions |
ISO |
1 |
237,205,702 |
237,997,288 |
RGD:6480464 |
CTD |
| G |
RYR2 |
ryanodine receptor 2 (cardiac) |
|
multiple interactions |
ISO |
1 |
237,205,702 |
237,997,288 |
RGD:6480464 |
CTD |
| G |
SAP18 |
Sin3A-associated protein, 18kDa |
|
multiple interactions |
ISO |
13 |
21,714,653 |
21,723,224 |
RGD:6480464 |
CTD |
| G |
SCFD1 |
sec1 family domain containing 1 |
|
decreases expression |
EXP |
14 |
31,091,460 |
31,205,034 |
RGD:6480464 |
CTD |
| G |
SEC13 |
SEC13 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
3 |
10,342,615 |
10,362,858 |
RGD:6480464 |
CTD |
| G |
SEC23A |
Sec23 homolog A (S. cerevisiae) |
|
decreases expression |
EXP |
14 |
39,501,123 |
39,572,437 |
RGD:6480464 |
CTD |
| G |
SENP6 |
SUMO1/sentrin specific peptidase 6 |
|
multiple interactions |
ISO |
6 |
76,311,622 |
76,427,997 |
RGD:6480464 |
CTD |
| G |
SEPT7 |
septin 7 |
|
multiple interactions |
ISO |
7 |
35,840,596 |
35,946,715 |
RGD:6480464 |
CTD |
| G |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
increases expression |
EXP |
14 |
94,843,084 |
94,857,029 |
RGD:6480464 |
CTD |
| G |
SERPINA6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
|
decreases expression |
EXP |
14 |
94,770,585 |
94,789,688 |
RGD:6480464 |
CTD |
| G |
SFPQ |
splicing factor proline/glutamine-rich |
|
multiple interactions |
ISO |
1 |
35,649,201 |
35,658,743 |
RGD:6480464 |
CTD |
| G |
SHARPIN |
SHANK-associated RH domain interactor |
|
increases expression |
ISO |
8 |
145,153,536 |
145,159,140 |
RGD:6480464 |
CTD |
| G |
SIGMAR1 |
sigma non-opioid intracellular receptor 1 |
|
decreases expression |
ISO |
9 |
34,634,719 |
34,637,768 |
RGD:6480464 |
CTD |
| G |
SLC16A1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
EXP |
1 |
113,454,469 |
113,498,975 |
RGD:6480464 |
CTD |
| G |
SLC16A1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
increases expression |
EXP |
1 |
113,454,469 |
113,498,975 |
RGD:6480464 |
CTD |
| G |
SLC17A5 |
solute carrier family 17 (anion/sugar transporter), member 5 |
|
increases expression |
ISO |
6 |
74,303,102 |
74,363,737 |
RGD:6480464 |
CTD |
| G |
SLC24A6 |
solute carrier family 24 (sodium/lithium/calcium exchanger), member 6 |
|
increases expression |
ISO |
12 |
113,736,571 |
113,772,925 |
RGD:6480464 |
CTD |
| G |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
|
decreases expression |
ISO |
8 |
23,386,363 |
23,430,063 |
RGD:6480464 |
CTD |
| G |
SLC30A7 |
solute carrier family 30 (zinc transporter), member 7 |
|
decreases expression |
ISO |
1 |
101,361,632 |
101,447,311 |
RGD:6480464 |
CTD |
| G |
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
5 |
1,392,905 |
1,445,543 |
RGD:6480464 |
CTD |
| G |
SMAD1 |
SMAD family member 1 |
|
multiple interactions |
ISO |
4 |
146,402,951 |
146,480,328 |
RGD:6480464 |
CTD |
| G |
SMAD3 |
SMAD family member 3 |
|
multiple interactions |
ISO |
15 |
67,358,195 |
67,487,533 |
RGD:6480464 |
CTD |
| G |
SMOX |
spermine oxidase |
|
increases expression |
EXP |
20 |
4,129,426 |
4,168,394 |
RGD:6480464 |
CTD |
| G |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
|
multiple interactions |
ISO |
16 |
68,392,230 |
68,482,409 |
RGD:6480464 |
CTD |
| G |
SNX3 |
sorting nexin 3 |
|
increases expression |
ISO |
6 |
108,532,717 |
108,582,464 |
RGD:6480464 |
CTD |
| G |
SQLE |
squalene epoxidase |
|
decreases expression |
ISO |
8 |
126,010,720 |
126,034,525 |
RGD:6480464 |
CTD |
| G |
SQLE |
squalene epoxidase |
|
decreases expression |
EXP |
8 |
126,010,720 |
126,034,525 |
RGD:6480464 |
CTD |
| G |
SQSTM1 |
sequestosome 1 |
|
increases expression |
ISO |
5 |
179,233,388 |
179,265,078 |
RGD:6480464 |
CTD |
| G |
SQSTM1 |
sequestosome 1 |
|
decreases expression |
EXP |
5 |
179,233,388 |
179,265,078 |
RGD:6480464 |
CTD |
| G |
SRP9 |
signal recognition particle 9kDa |
|
multiple interactions |
ISO |
1 |
225,965,515 |
225,978,168 |
RGD:6480464 |
CTD |
| G |
SRSF1 |
serine/arginine-rich splicing factor 1 |
|
decreases expression |
EXP |
17 |
56,078,280 |
56,084,707 |
RGD:6480464 |
CTD |
| G |
STAR |
steroidogenic acute regulatory protein |
|
increases expression |
EXP |
8 |
38,000,218 |
38,008,600 |
RGD:6480464 |
CTD |
| G |
STAR |
steroidogenic acute regulatory protein |
|
decreases methylation |
EXP |
8 |
38,000,218 |
38,008,600 |
RGD:6480464 |
CTD |
| G |
STARD4 |
StAR-related lipid transfer (START) domain containing 4 |
|
decreases expression |
ISO |
5 |
110,834,022 |
110,848,157 |
RGD:6480464 |
CTD |
| G |
STIM1 |
stromal interaction molecule 1 |
|
increases expression |
ISO |
11 |
3,876,933 |
4,114,440 |
RGD:6480464 |
CTD |
| G |
STIP1 |
stress-induced-phosphoprotein 1 |
|
multiple interactions |
ISO |
11 |
63,953,587 |
63,972,020 |
RGD:6480464 |
CTD |
| G |
STMN1 |
stathmin 1 |
|
increases expression |
ISO |
1 |
26,210,677 |
26,233,368 |
RGD:6480464 |
CTD |
| G |
STRBP |
spermatid perinuclear RNA binding protein |
|
decreases expression |
EXP |
9 |
125,883,899 |
126,030,855 |
RGD:6480464 |
CTD |
| G |
STX4 |
syntaxin 4 |
|
multiple interactions |
ISO |
16 |
31,044,903 |
31,051,485 |
RGD:6480464 |
CTD |
| G |
SYT4 |
synaptotagmin IV |
|
multiple interactions |
ISO |
18 |
40,847,857 |
40,857,615 |
RGD:6480464 |
CTD |
| G |
TAF1D |
TATA box binding protein (TBP)-associated factor, RNA polymerase I, D, 41kDa |
|
decreases expression |
ISO |
11 |
93,469,095 |
93,474,703 |
RGD:6480464 |
CTD |
| G |
TBRG4 |
transforming growth factor beta regulator 4 |
|
decreases expression |
ISO |
7 |
45,139,699 |
45,151,346 |
RGD:6480464 |
CTD |
| G |
TDO2 |
tryptophan 2,3-dioxygenase |
|
increases activity |
ISO |
4 |
156,824,845 |
156,841,558 |
RGD:6480464 |
CTD |
| G |
TFDP1 |
transcription factor Dp-1 |
|
decreases expression |
EXP |
13 |
114,239,003 |
114,295,788 |
RGD:6480464 |
CTD |
| G |
TFRC |
transferrin receptor (p90, CD71) |
|
multiple interactions |
ISO |
3 |
195,776,155 |
195,809,032 |
RGD:6480464 |
CTD |
| G |
TH |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
11 |
2,185,159 |
2,193,035 |
RGD:6480464 |
CTD |
| G |
TH |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
11 |
2,185,159 |
2,193,035 |
RGD:6480464 |
CTD |
| G |
TIRAP |
toll-interleukin 1 receptor (TIR) domain containing adaptor protein |
|
multiple interactions |
ISO |
11 |
126,152,982 |
126,164,828 |
RGD:6480464 |
CTD |
| G |
TLCD1 |
TLC domain containing 1 |
|
decreases expression |
ISO |
17 |
27,051,366 |
27,053,949 |
RGD:6480464 |
CTD |
| G |
TM9SF1 |
transmembrane 9 superfamily member 1 |
|
decreases expression |
EXP |
14 |
24,658,353 |
24,664,882 |
RGD:6480464 |
CTD |
| G |
TMCC2 |
transmembrane and coiled-coil domain family 2 |
|
increases expression |
EXP |
1 |
205,197,038 |
205,242,471 |
RGD:6480464 |
CTD |
| G |
TMED5 |
transmembrane emp24 protein transport domain containing 5 |
|
decreases expression |
ISO |
1 |
93,615,299 |
93,646,246 |
RGD:6480464 |
CTD |
| G |
TMEM69 |
transmembrane protein 69 |
|
decreases expression |
ISO |
1 |
46,153,847 |
46,160,108 |
RGD:6480464 |
CTD |
| G |
TMEM97 |
transmembrane protein 97 |
|
decreases expression |
EXP |
17 |
26,646,121 |
26,655,711 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFRSF19 |
tumor necrosis factor receptor superfamily, member 19 |
|
increases expression |
ISO |
13 |
24,144,509 |
24,250,244 |
RGD:6480464 |
CTD |
| G |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
|
increases expression |
EXP |
1 |
173,152,870 |
173,176,471 |
RGD:6480464 |
CTD |
| G |
TNK2 |
tyrosine kinase, non-receptor, 2 |
|
multiple interactions |
ISO |
3 |
195,590,236 |
195,635,880 |
RGD:6480464 |
CTD |
| G |
TNKS2 |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 |
|
increases expression |
ISO |
10 |
93,558,151 |
93,625,232 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
increases phosphorylation |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases mutagenesis |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TPH2 |
tryptophan hydroxylase 2 |
|
multiple interactions |
ISO |
12 |
72,332,626 |
72,426,221 |
RGD:6480464 |
CTD |
| G |
TPP2 |
tripeptidyl peptidase II |
|
multiple interactions |
ISO |
13 |
103,249,286 |
103,331,524 |
RGD:6480464 |
CTD |
| G |
TPRA1 |
transmembrane protein, adipocyte asscociated 1 |
|
increases expression |
ISO |
3 |
127,291,908 |
127,309,568 |
RGD:6480464 |
CTD |
| G |
TRPC3 |
transient receptor potential cation channel, subfamily C, member 3 |
|
multiple interactions |
ISO |
4 |
122,800,183 |
122,872,909 |
RGD:6480464 |
CTD |
| G |
TSC22D1 |
TSC22 domain family, member 1 |
|
multiple interactions |
ISO |
13 |
45,006,279 |
45,150,701 |
RGD:6480464 |
CTD |
| G |
TXNRD1 |
thioredoxin reductase 1 |
|
decreases expression |
EXP |
12 |
104,609,557 |
104,744,085 |
RGD:6480464 |
CTD |
| G |
TYMS |
thymidylate synthetase |
|
decreases expression |
ISO |
18 |
657,604 |
673,499 |
RGD:6480464 |
CTD |
| G |
TYW5 |
tRNA-yW synthesizing protein 5 |
|
decreases expression |
ISO |
2 |
200,793,634 |
200,820,459 |
RGD:6480464 |
CTD |
| G |
UBB |
ubiquitin B |
|
multiple interactions |
ISO |
17 |
16,284,367 |
16,286,054 |
RGD:6480464 |
CTD |
| G |
UBC |
ubiquitin C |
|
multiple interactions |
ISO |
12 |
125,396,192 |
125,399,587 |
RGD:6480464 |
CTD |
| G |
UBE2D2 |
ubiquitin-conjugating enzyme E2D 2 |
|
multiple interactions |
ISO |
5 |
138,940,751 |
139,008,019 |
RGD:6480464 |
CTD |
| G |
UBIAD1 |
UbiA prenyltransferase domain containing 1 |
|
decreases expression |
ISO |
1 |
11,333,255 |
11,348,491 |
RGD:6480464 |
CTD |
| G |
UCHL1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
multiple interactions |
ISO |
4 |
41,258,898 |
41,270,446 |
RGD:6480464 |
CTD |
| G |
UGT1A1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
increases expression |
EXP |
2 |
234,668,919 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
|
decreases expression |
EXP |
16 |
21,964,609 |
21,994,668 |
RGD:6480464 |
CTD |
| G |
UROS |
uroporphyrinogen III synthase |
|
multiple interactions |
ISO |
10 |
127,477,147 |
127,511,837 |
RGD:6480464 |
CTD |
| G |
USP11 |
ubiquitin specific peptidase 11 |
|
increases expression |
ISO |
X |
47,092,314 |
47,107,727 |
RGD:6480464 |
CTD |
| G |
UTP18 |
UTP18 small subunit (SSU) processome component homolog (yeast) |
|
decreases expression |
ISO |
17 |
49,337,897 |
49,375,294 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases expression |
ISO |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VPS41 |
vacuolar protein sorting 41 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
7 |
38,763,543 |
38,948,800 |
RGD:6480464 |
CTD |
| G |
WBP4 |
WW domain binding protein 4 |
|
multiple interactions |
ISO |
13 |
41,635,697 |
41,658,139 |
RGD:6480464 |
CTD |
| G |
WDR43 |
WD repeat domain 43 |
|
decreases expression |
ISO |
2 |
29,117,533 |
29,171,080 |
RGD:6480464 |
CTD |
| G |
WNT4 |
wingless-type MMTV integration site family, member 4 |
|
affects expression |
ISO |
1 |
22,443,798 |
22,469,519 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XDH |
xanthine dehydrogenase |
|
affects metabolic processing |
EXP |
2 |
31,557,188 |
31,637,611 |
RGD:6480464 |
CTD |
| G |
XKR5 |
XK, Kell blood group complex subunit-related family, member 5 |
|
decreases expression |
ISO |
8 |
6,666,038 |
6,693,166 |
RGD:6480464 |
CTD |
| G |
YWHAQ |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
|
multiple interactions |
EXP |
2 |
9,724,106 |
9,771,106 |
RGD:6480464 |
CTD |
| G |
ZNF175 |
zinc finger protein 175 |
|
decreases expression |
ISO |
19 |
52,074,531 |
52,092,991 |
RGD:6480464 |
CTD |
| G |
ZNF276 |
zinc finger protein 276 |
|
decreases expression |
ISO |
16 |
89,787,393 |
89,807,333 |
RGD:6480464 |
CTD |
| G |
ZNF37A |
zinc finger protein 37A |
|
increases expression |
EXP |
10 |
38,383,264 |
38,412,280 |
RGD:6480464 |
CTD |
| G |
ZNF553 |
zinc finger protein 553 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
Term paths to the root
|